- Tel: 858.663.9055
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Alpha-2-Macroglobulin Antibody reagents target alpha-2-macroglobulin (A2M), a large plasma glycoprotein and broad-spectrum protease inhibitor. As part of the innate immune system, A2M acts as a molecular trap for proteases, capturing them within its structure and targeting them for clearance. This function protects tissues from excessive protease activity during inflammation, coagulation, and tissue remodeling.
Alpha-2-macroglobulin is produced mainly in the liver and circulates at high levels in plasma. Beyond protease inhibition, it binds cytokines, growth factors, and amyloid-beta, linking it to inflammation, coagulation, wound repair, and neurodegeneration. Dysregulated A2M has been implicated in disorders ranging from Alzheimer’s disease to arthritis, kidney disease, and cancer.
Because of its central roles, the Alpha-2-Macroglobulin Antibody is an essential reagent for studying protease biology, immune regulation, and disease mechanisms. The A2M Antibody complements this research by providing reproducible detection across diverse assay systems.
NSJ Bioreagents provides Alpha-2-Macroglobulin Antibodies validated for immunohistochemistry (IHC), western blotting (WB), immunofluorescence (IF), flow cytometry (FACS), and ELISA. Each antibody undergoes rigorous validation for specificity, reproducibility, and performance.
Benefits include:
Comprehensive Validation: Confirmed across multiple techniques and sample types.
Reproducibility: Guaranteed batch-to-batch consistency.
Versatility: Suitable for plasma, tissue sections, and cell culture models.
Technical Support: Datasheets include protocols and suggested controls.
Translational Relevance: Useful in biomarker-driven studies and clinical pipelines.
By selecting NSJ Bioreagents, researchers can rely on the Alpha-2-Macroglobulin Antibody for consistent results across discovery and translational applications.
The Alpha-2-Macroglobulin Antibody supports broad applications in protease biology, immunity, and translational medicine.
Detect A2M binding to serine, cysteine, and metalloproteases.
Clarify its function as a molecular protease trap.
Support studies of protease balance in inflammation and coagulation.
Provide biomarkers for tissue injury and repair.
Alpha-2-Macroglobulin Antibody detects elevated levels during systemic inflammation.
Support studies of cytokine binding and clearance.
Clarify its regulatory role in immune modulation.
Extend into autoimmune and chronic inflammatory diseases.
Detect A2M expression during clot formation and fibrinolysis.
Support studies of protease regulation in wound repair.
Provide translational markers for coagulation disorders.
Extend into regenerative medicine pipelines.
Alpha-2-Macroglobulin Antibody detects interactions with amyloid-beta.
Support research into clearance mechanisms of amyloid plaques.
Provide biomarkers for Alzheimer’s disease progression.
Extend into translational neuroscience and therapeutic development.
Detect altered A2M expression in tumor microenvironments.
Support studies of protease activity in invasion and metastasis.
Validate biomarkers for tumor progression and therapeutic response.
Extend into biomarker-driven oncology research.
Alpha-2-Macroglobulin Antibody detects changes in renal and hepatic disorders.
Support studies of plasma protein turnover and clearance.
Provide biomarkers for nephrotic syndrome and cirrhosis.
Extend into clinical nephrology and hepatology pipelines.
Detect A2M’s protective roles in sepsis and pathogen defense.
Support studies of protease regulation during infection.
Provide biomarkers for systemic host responses.
Extend into translational infectious disease research.
Alpha-2-Macroglobulin Antibody is used in biomarker-driven plasma studies.
Supports diagnostics for inflammation, neurodegeneration, and cancer.
Provides reproducibility in clinical assay development.
Bridges discovery with translational medicine.
A2M is a multifunctional glycoprotein that serves as both a protease inhibitor and a carrier for bioactive molecules. The Alpha-2-Macroglobulin Antibody equips researchers to study these diverse functions across biology and disease.
In immunology, it clarifies how A2M regulates protease cascades and cytokine signaling. In neurobiology, it highlights roles in amyloid-beta binding and Alzheimer’s disease. In oncology, it supports studies of tumor invasion and microenvironment remodeling. In nephrology and hepatology, it provides biomarkers for systemic protein imbalance.
Clinically, A2M is being investigated as a biomarker for Alzheimer’s, sepsis, arthritis, and cancer. Reliable A2M Antibody reagents ensure reproducibility across laboratory and clinical pipelines.
Alpha-2-macroglobulin is a central regulator of protease activity, immune modulation, and disease pathology. The Alpha-2-Macroglobulin Antibody provides validated tools for protease biology, inflammation, neurodegeneration, and oncology, while the A2M Antibody complements these applications across translational and clinical research. By ensuring specificity, reproducibility, and versatility, these antibodies remain indispensable for advancing biomedical discovery and improving clinical outcomes.
IHC staining of FFPE human liver tissue with Alpha-2-Macroglobulin antibody (clone A2M/3622, cat # V9469). HIER: boil tissue sections in pH 9 10mM Tris with 1mM EDTA for 20 min and allow to cool before testing.
| ||
![]() |
| ||
![]() |